Deals, mergers, partnerships, and acquisitions are key mechanisms as health organizations look to enter new markets, differentiate their value proposition, and achieve growth strategies. Despite a less than favorable economic environment, the health industry has seen some major headlines in this space this year. Jen and Mindy are joined by Vynamic’s Deal Activation & Partnership Enablement Service Leads, Sean Martin and Kevin Fletcher, to discuss what’s driving these deals and what health industry leaders should be thinking about to maximize their value.

For more information about the work discussed in this episode, visit https://vynamic.com/what-we-do/services/deal-activation-partnership-enablement/

Podcast Tags: healthcare, healthcare news, mergers, acquisitions, deal activation, partnerships, health services, payers, providers, life sciences 

Source Links:

• Optimistic outlook for deals through 2023 
• M&A and venture trends in life sciences in 2023 
• A Look at Q2 M&A and Beyond: Are Conditions Ripe for a Strong 2024 M&A Rebound? 
• The Kaiser Permanente-Geisinger deal: Questions and answers 
• CVS closed $8B deal for health services company Signify Health 
• Pfizer buys Seagen for $43B, boosts access to cancer drugs 
• Amgen completes $27.8 billion Horizon Therapeutics deal 

Panel – Sean Martin, Kevin Fletcher, Mindy McGrath, Jen Burke

Research & Production – Adrea Cope, Jen Burke

Recording & Editing – Mike Liberto, Rachel Skonecki

For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.